News

Filter

Current filters:

Hospira

1 to 9 of 53 results

Hospira fourth-qtr 2014 earnings beat expectations

Hospira fourth-qtr 2014 earnings beat expectations

12-02-2015

US drugmaker Hospira, a leading provider of injectable drugs and infusion technologies, and a global…

FinancialGenericsHospiraPfizerUnited States

Pfenex soars on Lucentis biosimilar deal with Hospira

Pfenex soars on Lucentis biosimilar deal with Hospira

10-02-2015

Shares of US clinical-stage biotech firm Pfenex leapt 28% to $8.85 in morning trading, after the company…

BiosimilarsBiotechnologyGenentechGlobalHospiraLicensingLucentisNovartisOphthalmicsPF582PfenexResearchRoche

GlobalData analyst views implications of Pfizer’s acquisition of Hospira

07-02-2015

Just days after gaining US Food and Drug Administration breakthrough approval for Ibrance (palbociclib)…

BiosimilarsHospiraMergers & AcquisitionsPfizerPharmaceutical

UPDATE: Pfizer to acquire Hospira for around $17 billion

UPDATE: Pfizer to acquire Hospira for around $17 billion

05-02-2015

US pharma giant Pfizer has entered into a definitive merger agreement to acquire Hospira, news of which…

BiosimilarsGenericsHospiraMergers & AcquisitionsPfizer

Hospira submits new BLA for epoetin alfa biosimilar In USA

12-01-2015

US injectable drugs and infusion technologies and biosimilars developer Hospira has submitted a Biologics…

AmgenBiosimilarsBiotechnologyepoetinEpogenHematologyHospiraJanssenJohnson & JohnsonProcritRegulationRetacritUSA

Hospira gains US FDA backing for non-opioid analgesic Dyloject

Hospira gains US FDA backing for non-opioid analgesic Dyloject

31-12-2014

US injectable drugs and infusion technologies specialist Hospira has received approval from the US Food…

DylojectHospiraNeurologicalPharmaceuticalRegulationUSA

1 to 9 of 53 results

COMPANY SPOTLIGHT

Menarini

Back to top